苑东生物：艾拉莫德片获得药品注册证书

Core Viewpoint - Yuan Dong Biotech (688513.SH) announced that its subsidiary Chengdu Shuo De Pharmaceutical Co., Ltd. has received the drug registration certificate for "Elaidomide Tablets" from the National Medical Products Administration, indicating a significant regulatory milestone for the company [1] Group 1 - The active ingredient of Elaidomide Tablets is Elaidomide, which is indicated for the treatment of active rheumatoid arthritis [1] - Elaidomide Tablets are classified as a Category B drug in the National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalog (2024) [1]